National Advisory Committee on Rural Health and Human Services, 38255-38256 [2019-16770]

Download as PDF jbell on DSK3GLQ082PROD with NOTICES Federal Register / Vol. 84, No. 151 / Tuesday, August 6, 2019 / Notices shelled; Lentil, succulent shelled. Contact: RD. 3. EPA File Symbol Numbers: 1021– EIEO; 1021–EIGN; 1021–EIGR; 1021– EIEI. Docket ID Number: EPA–HQ– OPP–2019–0280. Applicant: MGK, 8810 Tenth Avenue North, Minneapolis, MN 55427–4319. Active Ingredient: SI–183 (1R-Phenothrin 98%). Product type: Insecticide. Proposed Use: Non-food indoor, outdoor, and residential uses. Contact: RD 4. EPA File Symbol Number: 1021– EIGE. Docket ID Number: EPA–HQ– OPP–2019–0364. Applicant: MGK; 8810 Tenth Avenue North; Minneapolis, MN 55427. Active ingredient: Metofluthrin. Product type: Insecticide. Proposed Use: Non-food outdoor residential broadcast spray. Contact: RD. 5. EPA Registration Number: 10308– 30. Docket ID Number: EPA–HQ–OPP– 2019–0364. Applicant: Sumitomo Chemical Co., Ltd.; 27–1 Shinkawa, 2chome, Chuo-ku, Tokyo, Japan 104– 8260 (c/o Technology Sciences Group; 1150 18th St. NW, Suite 1000, Washington, DC 20036). Active ingredient: Metofluthrin. Product type: Insecticide. Proposed Use: Non-food outdoor residential broadcast spray. Contact: RD. 6. EPA File Symbol Number: 10308– GT. Docket ID Number: EPA–HQ–OPP– 2019–0280). Applicant: Sumitomo Chemical Company, Ltd., 27–1 Shinkawa, 2-Chome, Chuo-Ku, Tokyo, Japan 104–8260 (c/o Technology Sciences Group Inc., 1150 18th St. NW Suite 1000, Washington, DC 20036). Active Ingredient: SI–183 (1RPhenothrin 98%). Product type: Insecticide. Proposed use: Non-food indoor, outdoor, and residential uses. Contact: RD. 7. EPA Registration Numbers: 59639– 185 and 59639–186. Docket ID Number: EPA–HQ–OPP–2019–0230. Applicant: Valent U.S.A. LLC, P.O. Box 8025, Walnut Creek, CA 94596–8025. Active ingredient: ethaboxam. Product type: fungicide. Proposed use: seed treatment on sugar beet. Contact: RD. 8. EPA File Symbol Number: 62719– TGT. Docket ID Number: EPA–HQ– OPP–2018–0645. Applicant: Dow AgroSciences LLC, 9330 Zionsville Road Indianapolis, IN 46268. Active ingredient: Florpyrauxifen-benzyl. Product type: Herbicide. Proposed uses: Grass forage, fodder, hay, and clover. Contact: RD. 9. EPA Registration Numbers: 71512– 7; 71512–9; 71512–10 and 71512–14. Docket ID Number: EPA–HQ–OPP– 2019–0250. Applicant: ISK Biosciences Corporation, 7470 Auburn Road, Suite A, Concord, Ohio 44077, requests to establish a tolerance for residues of the VerDate Sep<11>2014 19:21 Aug 05, 2019 Jkt 247001 insecticide flonicamid in or on greenhouse lettuce, and an increase in the existing tolerance for leafy greens subgroup 4–16A. Adequate enforcement methodology (FMC Method No. P– 3561M, a liquid chromatography with tandem mass spectrometry (LC/MS/MS) method) is available to enforce the tolerance expression for flonicamid and its metabolites in or on plant commodities. Contact: RD. 10. EPA Registration Number: 87301– 1. Docket ID Number: EPA–HQ–OPP– 2010–0247. Applicant: Biocontrol Technologies, S.L., Avgda. Madrid, 215– 217, entreso`l A, 08014 Barcelona, Spain (c/o Wagner Regulatory Associates, Inc., P.O. Box 640, Hockessin, DE 19707). Active ingredient: Trichoderma asperellum, strain T34. Product type: Fungicide and Bactericide. Proposed use: For use outdoors and on food in agricultural and residential settings to protect plants against diseases. Contact: BPPD. Authority: 7 U.S.C. 136 et seq. Dated: July 24, 2019. Delores Barber, Director, Information Technology and Resources Management Division, Office of Pesticide Programs. [FR Doc. 2019–16732 Filed 8–5–19; 8:45 am] BILLING CODE 6560–50–P 38255 (NORACoordinator@cdc.gov), National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Mailstop E–20, 1600 Clifton Road NE, Atlanta, GA 30329, phone (404) 498–2581 (not a toll free number). SUPPLEMENTARY INFORMATION: On February 5, 2019, NIOSH published a request for public review in the Federal Register [84 FR 1736] of the draft version of the National Occupational Research Agenda for Hearing Loss Prevention. NIOSH received three comments, which were reviewed and addressed where appropriate. In the final document, an additional research need was added, to perform targeted surveillance of worker hearing, cardiovascular health, mental health, and related health outcomes within worker populations with limited available research, such as workers in small construction firms, landscaping companies, restaurants, bars, sports arenas and complexes, music venues, and within public service. A response to Public Comment document can be found in the Supporting Documents section on www.regulations.gov for this docket. John J. Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. [FR Doc. 2019–16743 Filed 8–5–19; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES [CDC–2019–0001; Docket Number NIOSH– 323] Health Resources and Services Administration Final National Occupational Research Agenda for Hearing Loss Prevention National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of availability. AGENCY: NIOSH announces the availability of the final National Occupational Research Agenda for Hearing Loss Prevention. DATES: The final document was published on July 30, 2019 on the CDC website. ADDRESSES: The document may be obtained at the following link: https:// www.cdc.gov/nora/councils/hlp/ agenda.html SUMMARY: FOR FURTHER INFORMATION CONTACT: Emily Novicki, M.A., M.P.H, PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 National Advisory Committee on Rural Health and Human Services Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: In accordance with the Federal Advisory Committee Act, this notice announces that the Secretary’s National Advisory Committee on Rural Health and Human Services (NACRHHS) has scheduled a public meeting. Information about NACRHHS and the agenda for this meeting can be found on the NACRHHS website at https://www.hrsa.gov/advisorycommittees/rural-health/index.html. DATES: September 9, 2019, 8:30 a.m.– 5:15 p.m. Eastern Time (ET). September 10, 2019, 8:30 a.m.–5:15 p.m. ET. September 11, 2019, 8:30 a.m.–11:15 a.m. ET. SUMMARY: E:\FR\FM\06AUN1.SGM 06AUN1 38256 Federal Register / Vol. 84, No. 151 / Tuesday, August 6, 2019 / Notices This meeting will be held in-person at the Hubert H. Humphrey Building, located at 200 Independence Avenue SW, Washington, DC 20201, on September 9, 2019. The meeting will be held in-person at the Residence Inn Washington, Capitol located at 333 E St. SW, Washington, DC 20024, on September 10, 2019, and September 11, 2019. FOR FURTHER INFORMATION CONTACT: Steven Hirsch, Administrative Coordinator at the Federal Office of Rural Health Policy, HRSA, 5600 Fishers Lane, 17W59D, Rockville, Maryland 20857; 301–443–7322; or shirsch@hrsa.gov. SUPPLEMENTARY INFORMATION: NACRHHS provides advice and recommendations to the Secretary of HHS (Secretary) on policy, program development, and other matters of significance concerning both rural health and rural human services. During the September 9, 2019, through September 11, 2019, meeting, NACRHHS will examine the current delivery of health care and human services in rural areas. Agenda items are subject to change as priorities dictate. Refer to the NACRHHS website for any updated information concerning the meeting. Members of the public will have the opportunity to provide comments. Public participants may submit written statements in advance of the scheduled meeting. Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to submit a written statement or make oral comments to NACRHHS should be sent to Steven Hirsch, using the contact information above, at least three business days prior to the meeting. Individuals who plan to attend and need special assistance or another reasonable accommodation should notify Steven Hirsch at the address and phone number listed above at least 10 business days prior to the meeting. Since the meeting on September 10, 2019, occurs in a federal government building, attendees must go through a security check to enter the building. Non-U.S. Citizen attendees must notify Steven Hirsch of their planned attendance at least 20 business days prior to the meeting in order to facilitate their entry into the building. All attendees are required to present government-issued identification prior to entry. jbell on DSK3GLQ082PROD with NOTICES ADDRESSES: Maria G. Button, Director, Division of the Executive Secretariat. [FR Doc. 2019–16770 Filed 8–5–19; 8:45 am] BILLING CODE 4165–15–P VerDate Sep<11>2014 19:21 Aug 05, 2019 Jkt 247001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Notice of Interest Rate on Overdue Debts Section 30.18 of the Department of Health and Human Services’ claims collection regulations (45 CFR part 30) provides that the Secretary shall charge an annual rate of interest, which is determined and fixed by the Secretary of the Treasury after considering private consumer rates of interest on the date that the Department of Health and Human Services becomes entitled to recovery. The rate cannot be lower than the Department of Treasury’s current value of funds rate or the applicable rate determined from the ‘‘Schedule of Certified Interest Rates with Range of Maturities’’ unless the Secretary waives interest in whole or part, or a different rate is prescribed by statute, contract, or repayment agreement. The Secretary of the Treasury may revise this rate quarterly. The Department of Health and Human Services publishes this rate in the Federal Register. The current rate of 105⁄8%, as fixed by the Secretary of the Treasury, is certified for the quarter ended June 30, 2019. This rate is based on the Interest Rates for Specific Legislation, ‘‘National Health Services Corps Scholarship Program (42 U.S.C. 254o(b)(1)(A))’’ and ‘‘National Research Service Award Program (42 U.S.C. 288(c)(4)(B)).’’ This interest rate will be applied to overdue debt until the Department of Health and Human Services publishes a revision. Dated: July 30, 2019. David C. Horn, Director, Office of Financial Policy and Reporting. [FR Doc. 2019–16747 Filed 8–5–19; 8:45 am] BILLING CODE 4150–04–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Indian Health Service Division of Epidemiology and Disease Prevention; Epidemiology Program for American Indian/Alaska Native Tribes and Urban Indian Communities Ending the HIV Epidemic in Indian Country Announcement Type: Competing Supplement Funding Announcement Number: HHS– 2019–IHS–EPI–0001 Assistance Listing (Catalog of Federal Domestic Assistance or CFDA) Number: 93.231 PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 Key Dates Application Deadline Date: September 5, 2019 Earliest Anticipated Start Date: September 30, 2019 I. Funding Opportunity Description Statutory Authority The Indian Health Service (IHS) Office of Public Health Support, Division of Epidemiology and Disease Prevention (DEDP), in partnership with the IHS Office of Clinical and Preventive Services (OCPS) National Human Immunodeficiency Virus (HIV) & Viral Hepatitis C (HCV) Program and the U.S. Department of Health and Human Services (HHS) Minority HIV/ AIDS Fund (MHAF) is accepting applications for competitive supplemental funds to enhance activities in the Epidemiology Program for American Indian/Alaska Native (AI/ AN) Tribes and Urban Indian communities. This program is funded by the Office of the Assistant Secretary for Health, HHS, is authorized under the statutory earmark for minority AIDS prevention and treatment activities, and is to be carried out pursuant to Title III of the Public Service Act. The funding is being made available through an intra-Departmental Delegation of Authority (IDDA) to award specific funding for fiscal year (FY) 2019. This program is described in the Assistance Listings located at https://beta.sam.gov (formerly known as Catalog of Federal Domestic Assistance) under 93.231. Background The Tribal Epidemiology Center (TEC) program was authorized by Congress in 1996 as a way to provide public health support to multiple Tribes and Urban Indian communities in each of the IHS Areas. Only current TEC grantees are eligible to apply for the competing supplemental funding under this announcement and must demonstrate that they have complied with previous terms and conditions of the TEC program. The Office of Infectious Disease and HIV/AIDS Policy (OIDP) is located within the Office of the Assistant Secretary for Health HHS. The OIDP has directed the IHS to make awards to conduct projects and activities in support of the Ending the HIV Epidemic: A Plan for America initiative (EHE). The purpose of MHAF is to reduce new HIV infections, improve HIV-related health outcomes, and to reduce HIV-related health disparities for racial and ethnic minority communities by supporting innovation, collaboration, and the integration of best practices, E:\FR\FM\06AUN1.SGM 06AUN1

Agencies

[Federal Register Volume 84, Number 151 (Tuesday, August 6, 2019)]
[Notices]
[Pages 38255-38256]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-16770]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


National Advisory Committee on Rural Health and Human Services

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Secretary's National Advisory Committee on 
Rural Health and Human Services (NACRHHS) has scheduled a public 
meeting. Information about NACRHHS and the agenda for this meeting can 
be found on the NACRHHS website at https://www.hrsa.gov/advisory-committees/rural-health/index.html.

DATES: September 9, 2019, 8:30 a.m.-5:15 p.m. Eastern Time (ET). 
September 10, 2019, 8:30 a.m.-5:15 p.m. ET. September 11, 2019, 8:30 
a.m.-11:15 a.m. ET.

[[Page 38256]]


ADDRESSES: This meeting will be held in-person at the Hubert H. 
Humphrey Building, located at 200 Independence Avenue SW, Washington, 
DC 20201, on September 9, 2019. The meeting will be held in-person at 
the Residence Inn Washington, Capitol located at 333 E St. SW, 
Washington, DC 20024, on September 10, 2019, and September 11, 2019.

FOR FURTHER INFORMATION CONTACT: Steven Hirsch, Administrative 
Coordinator at the Federal Office of Rural Health Policy, HRSA, 5600 
Fishers Lane, 17W59D, Rockville, Maryland 20857; 301-443-7322; or 
[email protected].

SUPPLEMENTARY INFORMATION: NACRHHS provides advice and recommendations 
to the Secretary of HHS (Secretary) on policy, program development, and 
other matters of significance concerning both rural health and rural 
human services.
    During the September 9, 2019, through September 11, 2019, meeting, 
NACRHHS will examine the current delivery of health care and human 
services in rural areas. Agenda items are subject to change as 
priorities dictate. Refer to the NACRHHS website for any updated 
information concerning the meeting.
    Members of the public will have the opportunity to provide 
comments. Public participants may submit written statements in advance 
of the scheduled meeting. Oral comments will be honored in the order 
they are requested and may be limited as time allows. Requests to 
submit a written statement or make oral comments to NACRHHS should be 
sent to Steven Hirsch, using the contact information above, at least 
three business days prior to the meeting. Individuals who plan to 
attend and need special assistance or another reasonable accommodation 
should notify Steven Hirsch at the address and phone number listed 
above at least 10 business days prior to the meeting. Since the meeting 
on September 10, 2019, occurs in a federal government building, 
attendees must go through a security check to enter the building. Non-
U.S. Citizen attendees must notify Steven Hirsch of their planned 
attendance at least 20 business days prior to the meeting in order to 
facilitate their entry into the building. All attendees are required to 
present government-issued identification prior to entry.

Maria G. Button,
Director, Division of the Executive Secretariat.
[FR Doc. 2019-16770 Filed 8-5-19; 8:45 am]
 BILLING CODE 4165-15-P